Drug Profile
Staphylococcal vaccine - SBL Vaccin
Latest Information Update: 27 Aug 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source; SBL Vaccin AB; Teknikbrostiftelsen
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Staphylococcal infections
Most Recent Events
- 22 Jan 1999 Preclinical development for Staphylococcal infections in Sweden (Unknown route)